London, UK--(Marketwire - September 19, 2007) -
SKYEPHARMA TO PRESENT AT UBS 2007
GLOBAL LIFE SCIENCES CONFERENCE
LONDON, UK, 19 September 2007-- SkyePharma PLC (LSE: SKP) announces today that
the Company's Chief Executive Officer, Frank Condella, will make a presentation
at the UBS 2007 Global Life Sciences Conference in New York. Mr Condella will
deliver his presentation on Thursday 27 September 2007 at 12.30 p.m. EDT (5.30
p.m. UKT). Investors may access an audio webcast of the presentation at
www.skyepharma.com under the Investor Relations tab.
For further information please contact:
SkyePharma PLC Frank Condella +44 20 7491 1777
Ken Cunningham
Peter Grant
Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113
Deborah Scott
Trout Group (US Enquiries) Christine Labaree +1 617 583 1308
Seth Lewis
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops new
formulations of known molecules to provide a clinical advantage and life-cycle
extension. The Company has eleven approved products in the areas of oral,
inhalation and topical delivery that are marketed throughout the world by
leading pharmaceutical companies.
For more information, visit
www.skyepharma.com
This information is provided by RNS
The company news service from the London Stock Exchange